These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6218584)

  • 1. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O; Fabricius K; Krueger E; Rueckert U
    Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia.
    Saito A
    Rev Infect Dis; 1982; 4 Suppl():S623-8. PubMed ID: 6218575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxalactam in serious infections: clinical, bacteriologic, and pharmacokinetic studies.
    Giamarellou H; Tsagarakis J; Daikos GK
    Rev Infect Dis; 1982; 4 Suppl():S629-38. PubMed ID: 6218576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of moxalactam therapy.
    Venezio FR; Westenfelder GO; Cook FV; Williams JE; Carruthers M; Reisberg BE; Emmerman J; Phair JP
    J Antimicrob Chemother; 1982 Nov; 10(5):435-43. PubMed ID: 6217184
    [No Abstract]   [Full Text] [Related]  

  • 6. Enterococcal infections in patients treated with moxalactam.
    Moellering RC
    Rev Infect Dis; 1982; 4 Suppl():S708-11. PubMed ID: 6218588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxalactam disodium (Moxam).
    Med Lett Drugs Ther; 1982 Feb; 24(602):13-4. PubMed ID: 6460163
    [No Abstract]   [Full Text] [Related]  

  • 8. [The French experience with moxalactam in pneumology].
    Leng B; Imbert Y; Coomans D
    Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drug evaluations: moxalactam (Moxam, Eli Lilly).
    Polk RE
    Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
    Bégué P; Safran C; Fleurette J; Brun Y; Floret D; Monnet P
    Sem Hop; 1983 Jun; 59(26):1972-6. PubMed ID: 6310789
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of lower respiratory tract infections with moxalactam.
    Lentino JR; Rytel MW; Moore E
    Antimicrob Agents Chemother; 1981 May; 19(5):801-6. PubMed ID: 6457557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.
    Platt R; Ehrlich SL; Afarian J; O'Brien TF; Pennington JE; Kass EH
    Antimicrob Agents Chemother; 1981 Sep; 20(3):351-5. PubMed ID: 6458233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
    Snepar R; Poporad G; Romano J; Levison ME
    Antimicrob Agents Chemother; 1981 Nov; 20(5):642-7. PubMed ID: 6459763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of moxalactam.
    Mathisen GE; Meyer RD; Thompson JM; Finegold SM
    Antimicrob Agents Chemother; 1982 May; 21(5):780-6. PubMed ID: 6213198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics, in vitro activity and clinical experience with lamoxactam].
    Klech H; Fiser I
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):369-78. PubMed ID: 6221244
    [No Abstract]   [Full Text] [Related]  

  • 17. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experiences with cefmetazole for peritonitis and biliary tract infections with special reference to excretion of cefmetazole into bile (author's transl)].
    Saito T; Yamada Y; Yokoyama S
    Jpn J Antibiot; 1979 Apr; 32(4):504-8. PubMed ID: 459081
    [No Abstract]   [Full Text] [Related]  

  • 19. Moxalactam treatment of anaerobic infections in cancer patients.
    Lagast H; Meunier-Carpentier F; Klastersky J
    Antimicrob Agents Chemother; 1982 Oct; 22(4):604-10. PubMed ID: 6217784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of moxalactam with emphasis on infections due to multidrug-resistant organisms in patients with renal insufficiency.
    Trager GM; Panwalker AP; Malow JB; Porembski PE; Ramirez CA; Zar FA
    Chemotherapy; 1981; 27(4):287-95. PubMed ID: 6454542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.